Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy.

Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy.
复制标题

DOI:
10.3390/ijms17091498
复制
发表时间:
2016-09-07
影响因子:
5.6
通讯作者:
Antonetti DA
Antonetti DA
中科院分区:
生物学2区
文献类型:
--
作者:
Bolinger MT;Antonetti DA

文献摘要

参考文献

被引文献

相似文献

糖尿病视网膜病变是工作年龄成人失明的主要原因,并且由于糖尿病发病率的上升,预计将成为未来重要的健康问题。抗血管内皮生长因子(VEGF)抗体的出现彻底改变了糖尿病视网膜病变的治疗,但一个显着的患者子集未能响应治疗。越来越多的证据表明,炎性细胞因子和趋化因子以外的VEGF可能有助于疾病的过程。目前的审查检查存在的非VEGF细胞因子在糖尿病视网膜病变患者的眼睛,并强调在相关的动物模型的机制途径。最后,讨论了包括激肽-激肽释放酶系统组分在内的新型药物靶标和新兴治疗方法,如抗HPTP(人蛋白酪氨酸磷酸酶)β抗体。认识到非VEGF对疾病发病机制的贡献可能会导致新的治疗方法,以加强对抗VEGF治疗无反应的患者的现有治疗。
Diabetic retinopathy is the leading cause of blindness in working age adults, and is projected to be a significant future health concern due to the rising incidence of diabetes. The recent advent of anti-vascular endothelial growth factor (VEGF) antibodies has revolutionized the treatment of diabetic retinopathy but a significant subset of patients fail to respond to treatment. Accumulating evidence indicates that inflammatory cytokines and chemokines other than VEGF may contribute to the disease process. The current review examines the presence of non-VEGF cytokines in the eyes of patients with diabetic retinopathy and highlights mechanistic pathways in relevant animal models. Finally, novel drug targets including components of the kinin–kallikrein system and emerging treatments such as anti-HPTP (human protein tyrosine phosphatase) β antibodies are discussed. Recognition of non-VEGF contributions to disease pathogenesis may lead to novel therapeutics to enhance existing treatments for patients who do not respond to anti-VEGF therapies.
DOI: 10.4172/2155-9899
发表时间: 2013
期刊: Journal of clinical & cellular immunology
影响因子: --
作者:
Abcouwer SF
通讯作者: Abcouwer SF
DOI: 10.1038/sj.bjp.0705210
发表时间: 2003-09-01
影响因子: 7.3
作者:
Abdouh, M;Khanjari, A;Hasséssian, HM
通讯作者: Hasséssian, HM
DOI: 10.1073/pnas.0808698106
发表时间: 2009-02-10
影响因子: 11.1
作者:
Argaw, Azeb Tadesse;Gurfein, Blake T.;John, Gareth R.
通讯作者: John, Gareth R.
DOI: 10.1016/j.ophtha.2012.09.014
发表时间: 2013-03-01
期刊: OPHTHALMOLOGY
影响因子: 13.7
作者:
Campochiaro, Peter A.;Quan Dong Nguyen;Kane, Frances E.
通讯作者: Kane, Frances E.
DOI: 10.1056/nejmoa1312524
发表时间: 2015-01-29
影响因子: 158.5
作者:
Bas, Murat;Greve, Jens;Hoffmann, Thomas K.
通讯作者: Hoffmann, Thomas K.